Merck’s Q3 Results Beat Expectations on Both Top and Bottom Lines, Multiple Institutions Raise Target Prices Life Science
Johnson & Johnson Raises Guidance Despite Litigation Pressure, Highlighting the Resilience of a Healthcare Giant Life Science
Bristol Myers Squibb Raises Full-Year Revenue Guidance as New Drugs Offset Patent Expiry Pressure on Older Drugs Life Science
Value Stocks Notch Biggest S&P 500 Win Since 2001: Is the Rotation a Warning? Life Science, Technology
Boston Scientific Faces Cyber Incident and Product Pressures, With Growth Expected to Be Flat in 2027 Life Science
Jazz Pharmaceuticals Accelerates Oncology Business Layout, Can It Reverse the Growth Slump Life Science
Eli Lilly Sets Trillion-Dollar Market Cap Record as Opportunities and Risks Emerge Together Life Science
Are AT&T and Zoetis Unjustly Punished as Rising Rates Cool Dividend Stock Appeal? Life Science, Technology
Bristol Myers Squibb Licenses In Anticancer Drug That Extends Progression-Free Survival, Why Investors Reacted Mutedly Life Science
